
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The PDGF/PDGFR pathway as a drug target
Natalia Papadopoulos, Johan Lennartsson
Molecular Aspects of Medicine (2017) Vol. 62, pp. 75-88
Closed Access | Times Cited: 251
Natalia Papadopoulos, Johan Lennartsson
Molecular Aspects of Medicine (2017) Vol. 62, pp. 75-88
Closed Access | Times Cited: 251
Showing 1-25 of 251 citing articles:
Effect of Stromal Cells in Tumor Microenvironment on Metastasis Initiation
Sen Guo, Chu‐Xia Deng
International Journal of Biological Sciences (2018) Vol. 14, Iss. 14, pp. 2083-2093
Open Access | Times Cited: 270
Sen Guo, Chu‐Xia Deng
International Journal of Biological Sciences (2018) Vol. 14, Iss. 14, pp. 2083-2093
Open Access | Times Cited: 270
Targeting fibrosis: mechanisms and clinical trials
Manyu Zhao, Liqun Wang, Mengzhu Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 253
Manyu Zhao, Liqun Wang, Mengzhu Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 253
Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas
William D. Tap, Andrew J. Wagner, Patrick Schöffski, et al.
JAMA (2020) Vol. 323, Iss. 13, pp. 1266-1266
Open Access | Times Cited: 235
William D. Tap, Andrew J. Wagner, Patrick Schöffski, et al.
JAMA (2020) Vol. 323, Iss. 13, pp. 1266-1266
Open Access | Times Cited: 235
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Yue Zhou, Lei Tao, Jiahao Qiu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 160
Yue Zhou, Lei Tao, Jiahao Qiu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 160
Mechanistic Pathogenesis of Endothelial Dysfunction in Diabetic Nephropathy and Retinopathy
Jing Yang, Zhangsuo Liu
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 146
Jing Yang, Zhangsuo Liu
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 146
Targeting the PDGF/PDGFR signaling pathway for cancer therapy: A review
Zou Xiang, Xi-Yu Tang, Zhongyuan Qu, et al.
International Journal of Biological Macromolecules (2022) Vol. 202, pp. 539-557
Closed Access | Times Cited: 144
Zou Xiang, Xi-Yu Tang, Zhongyuan Qu, et al.
International Journal of Biological Macromolecules (2022) Vol. 202, pp. 539-557
Closed Access | Times Cited: 144
Cancer Stem Cells—Key Players in Tumor Relapse
Monica Marzagalli, Fabrizio Fontana, M. Raimondi, et al.
Cancers (2021) Vol. 13, Iss. 3, pp. 376-376
Open Access | Times Cited: 118
Monica Marzagalli, Fabrizio Fontana, M. Raimondi, et al.
Cancers (2021) Vol. 13, Iss. 3, pp. 376-376
Open Access | Times Cited: 118
Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies
Changyu Yao, Shilun Wu, Jian Kong, et al.
Cancer Biology and Medicine (2023) Vol. 20, Iss. 1, pp. 25-43
Open Access | Times Cited: 78
Changyu Yao, Shilun Wu, Jian Kong, et al.
Cancer Biology and Medicine (2023) Vol. 20, Iss. 1, pp. 25-43
Open Access | Times Cited: 78
Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy
Xiujuan Liu, Hong-Cheng Zhao, Su-Juan Hou, et al.
Bioorganic Chemistry (2023) Vol. 133, pp. 106425-106425
Closed Access | Times Cited: 78
Xiujuan Liu, Hong-Cheng Zhao, Su-Juan Hou, et al.
Bioorganic Chemistry (2023) Vol. 133, pp. 106425-106425
Closed Access | Times Cited: 78
New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies
Pratibha Pandey, Fahad Khan, Tarun Kumar Upadhyay, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114491-114491
Open Access | Times Cited: 73
Pratibha Pandey, Fahad Khan, Tarun Kumar Upadhyay, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114491-114491
Open Access | Times Cited: 73
Role of Cytokines and Chemokines in Angiogenesis in a Tumor Context
Mannon Geindreau, Mélanie Bruchard, Frédérique Végran
Cancers (2022) Vol. 14, Iss. 10, pp. 2446-2446
Open Access | Times Cited: 70
Mannon Geindreau, Mélanie Bruchard, Frédérique Végran
Cancers (2022) Vol. 14, Iss. 10, pp. 2446-2446
Open Access | Times Cited: 70
Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy
Tianchen Guo, Junfen Xu
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 3, pp. 1095-1116
Open Access | Times Cited: 31
Tianchen Guo, Junfen Xu
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 3, pp. 1095-1116
Open Access | Times Cited: 31
Hepatocellular Carcinoma: Old and Emerging Therapeutic Targets
Greta Pessino, Claudia Scotti, Maristella Maggi
Cancers (2024) Vol. 16, Iss. 5, pp. 901-901
Open Access | Times Cited: 19
Greta Pessino, Claudia Scotti, Maristella Maggi
Cancers (2024) Vol. 16, Iss. 5, pp. 901-901
Open Access | Times Cited: 19
Hepatocellular carcinoma: signaling pathways and therapeutic advances
Jiaojiao Zheng, Siying Wang, Lei Xia, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Jiaojiao Zheng, Siying Wang, Lei Xia, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Lipid Rafts in Signalling, Diseases, and Infections: What Can Be Learned from Fluorescence Techniques?
Sara Anselmo, Elisa Bonaccorso, Chiara M. A. Gangemi, et al.
Membranes (2025) Vol. 15, Iss. 1, pp. 6-6
Open Access | Times Cited: 3
Sara Anselmo, Elisa Bonaccorso, Chiara M. A. Gangemi, et al.
Membranes (2025) Vol. 15, Iss. 1, pp. 6-6
Open Access | Times Cited: 3
The role of small molecule platelet-derived growth factor receptor (PDGFR) inhibitors in the treatment of neoplastic disorders
Robert Roskoski
Pharmacological Research (2018) Vol. 129, pp. 65-83
Closed Access | Times Cited: 144
Robert Roskoski
Pharmacological Research (2018) Vol. 129, pp. 65-83
Closed Access | Times Cited: 144
Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy
Zhaoying Fu, Jim Xiang
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 2793-2793
Open Access | Times Cited: 109
Zhaoying Fu, Jim Xiang
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 2793-2793
Open Access | Times Cited: 109
Genes and Mechanisms Involved in the Generation and Amplification of Basal Radial Glial Cells
Maxime Penisson, Julia Ladewig, Richard Belvindrah, et al.
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 89
Maxime Penisson, Julia Ladewig, Richard Belvindrah, et al.
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 89
Angiogenesis as a potential treatment strategy for rheumatoid arthritis
Yan Wang, Hong Wu, Ran Deng
European Journal of Pharmacology (2021) Vol. 910, pp. 174500-174500
Closed Access | Times Cited: 77
Yan Wang, Hong Wu, Ran Deng
European Journal of Pharmacology (2021) Vol. 910, pp. 174500-174500
Closed Access | Times Cited: 77
Tyrosine Kinase Receptors in Oncology
Jorge Esteban-Villarrubia, J.J. Soto Castillo, Javier Pozas, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8529-8529
Open Access | Times Cited: 76
Jorge Esteban-Villarrubia, J.J. Soto Castillo, Javier Pozas, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8529-8529
Open Access | Times Cited: 76
Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH
Na Zhu, Emilia M. Swietlik, Carrie L. Welch, et al.
Genome Medicine (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 65
Na Zhu, Emilia M. Swietlik, Carrie L. Welch, et al.
Genome Medicine (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 65
Current Status and Prospects of Targeted Therapy for Osteosarcoma
Zunguo Hu, Shuang Wen, Zijun Huo, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3507-3507
Open Access | Times Cited: 55
Zunguo Hu, Shuang Wen, Zijun Huo, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3507-3507
Open Access | Times Cited: 55
Pharmacological Mechanisms and Clinical Applications of Curcumin: Update
Min Hao, Yue Chu, Lei Jing-xuan, et al.
Aging and Disease (2022) Vol. 14, Iss. 3, pp. 716-716
Open Access | Times Cited: 50
Min Hao, Yue Chu, Lei Jing-xuan, et al.
Aging and Disease (2022) Vol. 14, Iss. 3, pp. 716-716
Open Access | Times Cited: 50
What is new in cancer-associated fibroblast biomarkers?
Zehua Zhao, Tianming Li, Yuan Yuan, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 32
Zehua Zhao, Tianming Li, Yuan Yuan, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 32
Adipose stem cells in tissue regeneration and repair: From bench to bedside
Lei Dong, Xiaoyu Li, Wenyuan Leng, et al.
Regenerative Therapy (2023) Vol. 24, pp. 547-560
Open Access | Times Cited: 27
Lei Dong, Xiaoyu Li, Wenyuan Leng, et al.
Regenerative Therapy (2023) Vol. 24, pp. 547-560
Open Access | Times Cited: 27